BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26860678)

  • 1. Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign.
    Agarwal S; Grajo JR; Fuentes-Orrego JM; Abtahi SM; Harisinghani MG; Saini S; Hahn PF
    Eur J Radiol; 2016 Mar; 85(3):635-40. PubMed ID: 26860678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
    Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
    AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
    Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
    J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.
    Kim B; Byun JH; Kim HJ; Won HJ; Kim SY; Shin YM; Kim PN
    Eur Radiol; 2016 Jan; 26(1):191-8. PubMed ID: 25933742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Hemangiomas: Factors Associated with Pseudo Washout Sign on Gd-EOB-DTPA-enhanced MR Imaging.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Nakamura F
    Magn Reson Med Sci; 2016; 15(1):73-82. PubMed ID: 26346400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
    Taibbi A; Brancatelli G; Matranga D; Midiri M; Lagalla R; Bartolotta TV
    Diagn Interv Radiol; 2019 Mar; 25(2):95-101. PubMed ID: 30860073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
    Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
    AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.
    Channual S; Tan N; Siripongsakun S; Lassman C; Lu DS; Raman SS
    AJR Am J Roentgenol; 2015 Sep; 205(3):546-53. PubMed ID: 26295640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM; Cerny M; Al Shaikh M; Billiard JS; OliviƩ D; Chagnon M; Tang A
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
    Pahade JK; Juice D; Staib L; Israel G; Cornfeld D; Mitchell K; Weinreb J
    Abdom Radiol (NY); 2016 Jul; 41(7):1270-84. PubMed ID: 26800701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
    Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
    Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.